Abstract
A 34-year-old primigravid woman presents for a routine prenatal visit at 18 weeks of gestation with a breast lump. On examination, she has a painless, firm breast mass measuring 3-4 cm in diameter with overlying skin dimpling. A diagnostic mammogram shows findings suspicious for malignancy (Breast Imaging Reporting and Data System [BI-RADS] 4), and core biopsy demonstrates an invasive ductal carcinoma with both estrogen and progesterone receptor-positive staining. The patient asks: "How will this affect my pregnancy, and what is the safest course of action?"
| Original language | English (US) |
|---|---|
| Pages (from-to) | 122-125 |
| Number of pages | 4 |
| Journal | Obstetrics and gynecology |
| Volume | 132 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1 2018 |
Fingerprint
ASJC Scopus subject areas
- Obstetrics and Gynecology
Cite this
Management strategy for breast cancer in pregnancy. / Kuo, Kelly; Caughey, Aaron.
In: Obstetrics and gynecology, Vol. 132, No. 1, 01.01.2018, p. 122-125.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Management strategy for breast cancer in pregnancy
AU - Kuo, Kelly
AU - Caughey, Aaron
PY - 2018/1/1
Y1 - 2018/1/1
N2 - A 34-year-old primigravid woman presents for a routine prenatal visit at 18 weeks of gestation with a breast lump. On examination, she has a painless, firm breast mass measuring 3-4 cm in diameter with overlying skin dimpling. A diagnostic mammogram shows findings suspicious for malignancy (Breast Imaging Reporting and Data System [BI-RADS] 4), and core biopsy demonstrates an invasive ductal carcinoma with both estrogen and progesterone receptor-positive staining. The patient asks: "How will this affect my pregnancy, and what is the safest course of action?"
AB - A 34-year-old primigravid woman presents for a routine prenatal visit at 18 weeks of gestation with a breast lump. On examination, she has a painless, firm breast mass measuring 3-4 cm in diameter with overlying skin dimpling. A diagnostic mammogram shows findings suspicious for malignancy (Breast Imaging Reporting and Data System [BI-RADS] 4), and core biopsy demonstrates an invasive ductal carcinoma with both estrogen and progesterone receptor-positive staining. The patient asks: "How will this affect my pregnancy, and what is the safest course of action?"
UR - http://www.scopus.com/inward/record.url?scp=85064354549&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064354549&partnerID=8YFLogxK
U2 - 10.1097/AOG.0000000000002647
DO - 10.1097/AOG.0000000000002647
M3 - Article
VL - 132
SP - 122
EP - 125
JO - Obstetrics and Gynecology
JF - Obstetrics and Gynecology
SN - 0029-7844
IS - 1
ER -